Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set

被引：0
|
作者：
A Lotery
R Griner
A Ferreira
F Milnes
P Dugel
机构：
[1] Eye Unit,
[2] University Hospital Southampton NHS Foundation Trust,undefined
[3] Clinical and Experimental Sciences,undefined
[4] Faculty of Medicine,undefined
[5] University of Southampton,undefined
[6] QuintilesIMS,undefined
[7] Novartis Pharma AG,undefined
[8] Retinal Consultants of Arizona LTD,undefined
来源：
Eye | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1697 / 1706
页数：9
相关论文
共 50 条
  • [21] Real study: Re-treatment evaluated on visual acuity for Lucentis® in neovascular AMD
    Bellocq, D.
    De Bats, F.
    Rabilloud, M.
    Kodjikian, L.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (05): : 397 - 401
  • [22] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88
  • [23] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Ian J Constable
    Ian L McAllister
    Timothy Isaacs
    [J]. International Journal of Ophthalmology, 2011, (01) : 85 - 88
  • [24] METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kim, Leah N.
    Mehta, Hemal
    Barthelmes, Daniel
    Vuong Nguyen
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1418 - 1431
  • [25] Intravitreal Aflibercept for Diabetic Macular Oedema in Real-world; 5-Year Visual Acuity and Anatomical Outcomes
    Lukic, Marko
    Hamilton, Robin
    Rajendram, Ranjan
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [26] Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomes
    Lukic, Marko
    Williams, Gwyn
    Shalchi, Zaid
    Patel, Praveen J.
    Hykin, Philip G.
    Hamilton, Robin D.
    Rajendram, Ranjan
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (03) : 1201 - 1207
  • [27] Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration
    Brynskov, Troels
    Munch, Inger Christine
    Larsen, Tobias Malte
    Erngaard, Iiv
    Sorensen, Torben Lykke
    [J]. ACTA OPHTHALMOLOGICA, 2020, 98 (02) : 132 - 138
  • [28] Predicting visual outcomes in patients treated with aflibercept for neovascular age-related macular degeneration: Data from a real-world clinical setting
    Fulcher, Corinne
    Hazel, Charlotte A.
    Pacey, Ian
    Ali, Hasan
    Ghanchi, Faruque D.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (03) : 543 - 549
  • [29] The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes
    Butt, Thomas
    Lee, Aaron
    Lee, Cecilia
    Tufail, Adnan
    [J]. BMJ OPEN, 2015, 5 (05):
  • [30] Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Kiss, Szilard
    Malangone-Monaco, Elisabetta
    Wilson, Kathleen
    Varker, Helen
    Stetsovsky, Diana
    Smith, David
    Garmo, Vincent
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (03): : 253 - 266
12345